Chemical laboratory scene: young PhD student scientist girl looking through a microscope. Side view of female medical worker in research laboratory (biochemistry genetics forensics microbiology)
America’s medical manufacturing industry is at a critical crossroads. Pandemics, natural disasters, and unfair competition from China have exposed the vulnerabilities in our nation’s health supply chain, and the stakes for action could not be higher.
Today, we have a unique opportunity to unite across party lines and branches of government to secure our medical manufacturing future. This is our moment.
President Trump supports domestic industries. Congress and the administration must work together to ensure our nation’s health security and economic resilience.
National leaders have a responsibility to act. The strength of medical manufacturing directly affects national security and economic stability. Ensuring a robust domestic supply chain for critical medical supplies is a health priority and a strategic imperative in the face of global competition and geopolitical risks.
Trump’s support for initiatives like the Make PPE in America Act underscores a commitment to safeguarding our domestic medical supply chains. These efforts deserve bipartisan backing to solidify our progress and address the remaining challenges.
Strengthening our domestic manufacturing base is not just about economic growth; it’s about protecting the health and safety of every American. Congressional leaders are urged to continue working to enact legislation and enforce existing policies to counter unfair trade actions.
We recently shared letters with Congress and the administration outlining issues for their urgent action.
—The Make PPE in America Act was a significant step forward, but implementation is crucial. The Departments of Veterans Affairs and Health and Human Services must finalize regulations to ensure all federal agencies uniformly prioritize domestically manufactured personal protective equipment. The Made in America Office must oversee implementation to prevent loopholes that allow reliance on foreign producers.
—The Administration for Strategic Preparedness and Response and the Office of Pandemic Preparedness and Response Policy are pivotal in safeguarding our nation’s health security. Ensuring the Strategic National Stockpile prioritizes American-made supplies will fortify our preparedness for future emergencies.
—Our reliance on foreign sources, particularly from China, poses significant risks. Policies that level the playing field for American manufacturers, including measures to counteract tariff circumvention, transhipments and exploitations of de minimus trade loopholes, among other unfair practices, are essential to building a resilient supply chain.
—Tax incentives can stimulate innovation and investment in domestic manufacturing. Extending the 100 percent bonus depreciation provision, reinstating immediate expensing for research and development, and introducing a Medical Supply Security Tax Credit will encourage growth and ensure the competitiveness of American-made medical supplies.
While presidential leadership is critical, congressional oversight is necessary to enforce the Make PPE in America Act, enhance trade enforcement, and support Medicare policies that favor domestic products. We applaud bipartisan efforts to reduce dependencies on adversarial foreign supply chains and strengthen U.S. manufacturing.
Achieving a resilient, American-led medical manufacturing base requires bold action. The time to act is now. By working together, we can ensure that the United States is never again at the mercy of foreign suppliers during a health crisis.
The stakes are too high for inaction. The medical manufacturing industry is not just another slice of the economy; it is a cornerstone of national security. Investing in this industry protects public health, creates high-skilled jobs, stimulates economic growth, and strengthens our economy.
Trump has laid the groundwork for robust domestic medical manufacturing. We, elected officials, industry leaders, public safety leaders and health advocates must build on that foundation. Together, we can secure America’s medical manufacturing future and ensure a healthier, more resilient nation for future generations.